Approved Digital Medication for Schizophrenia Schizophrenia
The first digital pill has been approved by the U.S. Food and Drug Administration (USFDA). The digital pill is embedded with an ingestible tracking sensor that tells the doctors whether, and when, patients take their medicine. The approved drug, Abilify MyCite contains aripiprazole which is an atypical antipsychotic that has been approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder. It is also used as an add-on treatment for depression in adults.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer